Bortezomib Related Products
Bortezomib is a medication used to treat multiple myeloma, a type of blood cancer.It is available as a generic medication.
Vsquare is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Bortezomib, pharmacopeial and non-pharmacopeial Bortezomib impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Bortezomib impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.
Bortezomib-related products are thoroughly characterized. Bortezomib products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.
Pharmaceutical Reference Standards
(S,R)-Bortezomib Hydroxyisopentyl Amide Analog
VS CAT No | : VV-B004005 |
CAS No | : 289472-78-2 |
Mol.F. | : C19H24N4O3 |
Mol.Wt. | : 356.4 |
Inv. Status | : In Stock |
Bortezomib
VS CAT No | : VV-B004001 |
CAS No | : 179324-69-7 |
Mol.F. | : C19H25BN4O4 |
Mol.Wt. | : 384.2 |
Inv. Status | : In Stock |
Bortezomib
VS CAT No | : VV-B004001 |
CAS No | : 179324-69-7 |
Mol.F. | : C19H25BN4O4 |
Mol.Wt. | : 384.2 |
Inv. Status | : In Stock |
Bortezomib Amino R Isomer (TFA salt)
VS CAT No | : VV-B004056 |
CAS No | : 179324-87-9 |
Mol.F. | : C15H28BNO2 : C2HF3O2 |
Mol.Wt. | : 265.2 : 114.0 |
Inv. Status | : In Stock |
Rel. CAS No | : 179324-86-8 (Free base) |
Bortezomib D-Mannitol Ester
VS CAT No | : VV-B004126 |
CAS No | : 444576-08-3 |
Mol.F. | : C25H35BN4O8 |
Mol.Wt. | : 530.4 |
Inv. Status | : In Stock |
Bortezomib Ester Impurity
VS CAT No | : VV-B004106 |
CAS No | : NA |
Mol.F. | : C29H39BN4O4 |
Mol.Wt. | : 518.5 |
Inv. Status | : In Stock |
Bortezomib Hydroxy Ketone Analog
VS CAT No | : VV-B004010 |
CAS No | : 2379402-85-2 |
Mol.F. | : C19H22N4O4 |
Mol.Wt. | : 370.4 |
Inv. Status | : In Stock |
Bortezomib Impurity (R,R-Isomer)
VS CAT No | : VV-B004002 |
CAS No | : 1132709-15-9 |
Mol.F. | : C19H25BN4O4 |
Mol.Wt. | : 384.2 |
Inv. Status | : In Stock |
Bortezomib Impurity (R,S-Isomer)
VS CAT No | : VV-B004003 |
CAS No | : 1132709-16-0 |
Mol.F. | : C19H25BN4O4 |
Mol.Wt. | : 384.2 |
Inv. Status | : In Stock |
Bortezomib Impurity (S,S-Isomer)
VS CAT No | : VV-B004004 |
CAS No | : 1132709-14-8 |
Mol.F. | : C19H25BN4O4 |
Mol.Wt. | : 384.2 |
Inv. Status | : In Stock |
Bortezomib Impurity 11
VS CAT No | : VV-B004016 |
CAS No | : 862895-00-9 |
Mol.F. | : C19H22N4O2 |
Mol.Wt. | : 338.4 |
Inv. Status | : In Stock |
Bortezomib Impurity 14
VS CAT No | : VV-B004019 |
CAS No | : 205393-22-2 |
Mol.F. | : C29H39BN4O4 |
Mol.Wt. | : 518.5 |
Inv. Status | : In Stock |
Rel. CAS No | : 1187479-73-7 (HCl salt) |
Bortezomib Impurity 15
VS CAT No | : VV-B004096 |
CAS No | : 1259365-04-2 |
Mol.F. | : C11H24BNO2 |
Mol.Wt. | : 213.1 |
Inv. Status | : In Stock |
Rel. CAS No | : 1259300-03-2 (HCl salt) |
Bortezomib Impurity 16
VS CAT No | : VV-B004021 |
CAS No | : NA |
Mol.F. | : C19H24N4O3 |
Mol.Wt. | : 356.4 |
Inv. Status | : In Stock |
Bortezomib Impurity 17
VS CAT No | : VV-B004022 |
CAS No | : NA |
Mol.F. | : C19H25BN4O5 |
Mol.Wt. | : 400.3 |
Inv. Status | : In Stock |
Bortezomib Impurity 18
VS CAT No | : VV-B004023 |
CAS No | : NA |
Mol.F. | : C38H46N8O6 |
Mol.Wt. | : 710.8 |
Inv. Status | : In Stock |
Bortezomib Impurity 2 (Mixture of (1S,2R)-Isomer and (1R,2R)-Isomer)
VS CAT No | : VV-B004007 |
CAS No | : 2747958-64-9 |
Mol.F. | : C19H24N4O3 |
Mol.Wt. | : 356.4 |
Inv. Status | : In Stock |
Bortezomib Impurity 2 (RR-Isomer)
VS CAT No | : VV-B004006 |
CAS No | : NA |
Mol.F. | : C19H24N4O3 |
Mol.Wt. | : 356.4 |
Inv. Status | : In Stock |
Bortezomib Impurity 20
VS CAT No | : VV-B004025 |
CAS No | : 89618-77-9 |
Mol.F. | : C14H24BClO2 |
Mol.Wt. | : 270.6 |
Inv. Status | : In Stock |
Bortezomib Impurity 21
VS CAT No | : VV-B004026 |
CAS No | : 94242-79-2 |
Mol.F. | : C20H42BNO2Si2 |
Mol.Wt. | : 395.6 |
Inv. Status | : In Stock |
Bortezomib Impurity 23
VS CAT No | : VV-B004028 |
CAS No | : NA |
Mol.F. | : C14H24BClO2 |
Mol.Wt. | : 270.6 |
Inv. Status | : In Stock |
Bortezomib Impurity 25
VS CAT No | : VV-B004097 |
CAS No | : 94242-80-5 |
Mol.F. | : C14H26BNO2 |
Mol.Wt. | : 251.2 |
Inv. Status | : In Stock |
Bortezomib Impurity 26
VS CAT No | : VV-B004031 |
CAS No | : 78-77-3 |
Mol.F. | : C4H9Br |
Mol.Wt. | : 137.0 |
Inv. Status | : In Stock |
Bortezomib Impurity 27
VS CAT No | : VV-B004032 |
CAS No | : 63-91-2 |
Mol.F. | : C9H11NO2 |
Mol.Wt. | : 165.2 |
Inv. Status | : In Stock |
Bortezomib Impurity 28
VS CAT No | : VV-B004033 |
CAS No | : 18942-49-9 |
Mol.F. | : C14H19NO4 |
Mol.Wt. | : 265.3 |
Inv. Status | : In Stock |
Rel. CAS No | : 169131-65-1 (HCl salt) ; 1013327-78-0 (Na salt) |
Bortezomib Impurity 29
VS CAT No | : VV-B004034 |
CAS No | : 89-01-0 |
Mol.F. | : C6H4N2O4 |
Mol.Wt. | : 168.1 |
Inv. Status | : In Stock |
Rel. CAS No | : 93778-20-2 (Na salt) ; 859063-48-2 (K salt) |
Bortezomib Impurity 3
VS CAT No | : VV-B004008 |
CAS No | : NA |
Mol.F. | : C14H14N4O2 : HCl |
Mol.Wt. | : 270.3 : 36.5 |
Inv. Status | : In Stock |
Rel. CAS No | : 2748159-75-1 (free base) |
Bortezomib Impurity 30
VS CAT No | : VV-B004035 |
CAS No | : 513-36-0 |
Mol.F. | : C4H9Cl |
Mol.Wt. | : 92.6 |
Inv. Status | : In Stock |
Bortezomib Impurity 31
VS CAT No | : VV-B004036 |
CAS No | : 84110-40-7 |
Mol.F. | : C4H11BO2 |
Mol.Wt. | : 101.9 |
Inv. Status | : In Stock |
Bortezomib Impurity 32
VS CAT No | : VV-B004037 |
CAS No | : 2363753-29-9 |
Mol.F. | : C15H28BNO2 : C2HF3O2 |
Mol.Wt. | : 265.2 : 114.0 |
Inv. Status | : In Stock |
Rel. CAS No | : 1173239-14-9 (Free base) |
Bortezomib Impurity 33
VS CAT No | : VV-B004038 |
CAS No | : 948294-96-0 |
Mol.F. | : C14H23BN2O3 |
Mol.Wt. | : 278.2 |
Inv. Status | : In Stock |
Rel. CAS No | : 2413962-44-2 (HCl salt) |
Bortezomib Impurity 35
VS CAT No | : VV-B004040 |
CAS No | : NA |
Mol.F. | : C28H34BN5O5 |
Mol.Wt. | : 531.4 |
Inv. Status | : In Stock |
Bortezomib Impurity 36
VS CAT No | : VV-B004041 |
CAS No | : 114457-94-2 |
Mol.F. | : C14H13N3O3 |
Mol.Wt. | : 271.3 |
Inv. Status | : In Stock |
Rel. CAS No | : 1093959-75-1 (Na salt) ; 1093959-76-2 (K salt) |
Bortezomib Impurity 37
VS CAT No | : VV-B004058 |
CAS No | : 1798895-16-5 |
Mol.F. | : C15H15N3O3 |
Mol.Wt. | : 285.3 |
Inv. Status | : In Stock |
Bortezomib Impurity 38
VS CAT No | : VV-B004059 |
CAS No | : 18680-27-8 |
Mol.F. | : C10H18O2 |
Mol.Wt. | : 170.3 |
Inv. Status | : In Stock |
Bortezomib Impurity 4
VS CAT No | : VV-B004009 |
CAS No | : 862894-96-0 |
Mol.F. | : C19H22N4O3 |
Mol.Wt. | : 354.4 |
Inv. Status | : In Stock |
Bortezomib Impurity 40
VS CAT No | : VV-B004061 |
CAS No | : 85167-14-2 |
Mol.F. | : C15H26BClO2 |
Mol.Wt. | : 284.6 |
Inv. Status | : In Stock |
Bortezomib Impurity 41
VS CAT No | : VV-B004064 |
CAS No | : 514820-48-5 |
Mol.F. | : C21H44BNO2Si2 |
Mol.Wt. | : 409.6 |
Inv. Status | : In Stock |
Bortezomib Impurity 42
VS CAT No | : VV-B004070 |
CAS No | : 477254-69-6 |
Mol.F. | : C15H28BNO2 : C2HF3O2 |
Mol.Wt. | : 265.2 : 114.0 |
Inv. Status | : In Stock |
Rel. CAS No | : 477254-68-5 (Free base) |
Bortezomib Impurity 43
VS CAT No | : VV-B004078 |
CAS No | : NA |
Mol.F. | : C28H37BN4O4 |
Mol.Wt. | : 504.4 |
Inv. Status | : In Stock |
Bortezomib Impurity 44
VS CAT No | : VV-B004080 |
CAS No | : 2308-61-4 |
Mol.F. | : C18H18N2O2 |
Mol.Wt. | : 294.4 |
Inv. Status | : In Stock |
Bortezomib Impurity 45
VS CAT No | : VV-B004082 |
CAS No | : 1255646-95-7 |
Mol.F. | : C17H18N2O3 |
Mol.Wt. | : 298.3 |
Inv. Status | : In Stock |
Bortezomib Impurity 46
VS CAT No | : VV-B004083 |
CAS No | : 2577-40-4 |
Mol.F. | : C18H20N2O3 |
Mol.Wt. | : 312.4 |
Inv. Status | : In Stock |
Rel. CAS No | : 68800-30-6 (HCl salt) ; 1087344-12-4 (HBr salt) ; 1841445-65-5 (Na salt) ; 1307315-69-0 (TFA salt) |
Bortezomib Impurity 47
VS CAT No | : VV-B004084 |
CAS No | : 1194235-14-7 |
Mol.F. | : C23H22N4O4 |
Mol.Wt. | : 418.5 |
Inv. Status | : In Stock |
Bortezomib Impurity 48
VS CAT No | : VV-B004085 |
CAS No | : NA |
Mol.F. | : C57H69B3N12O9 |
Mol.Wt. | : 1098.7 |
Inv. Status | : In Stock |
Bortezomib Impurity 50
VS CAT No | : VV-B004087 |
CAS No | : NA |
Mol.F. | : C57H69B3N12O9 |
Mol.Wt. | : 1098.7 |
Inv. Status | : In Stock |
Bortezomib Impurity 51
VS CAT No | : VV-B004088 |
CAS No | : NA |
Mol.F. | : C27H35BN4O4 |
Mol.Wt. | : 490.4 |
Inv. Status | : In Stock |
Bortezomib Impurity 53
VS CAT No | : VV-B004090 |
CAS No | : 2364553-64-8 |
Mol.F. | : C14H13N3O3 |
Mol.Wt. | : 271.3 |
Inv. Status | : In Stock |
Bortezomib Impurity 54
VS CAT No | : VV-B004091 |
CAS No | : 110755-29-8 |
Mol.F. | : C14H22N2O |
Mol.Wt. | : 234.3 |
Inv. Status | : In Stock |
Rel. CAS No | : 292061-26-8 (HCl salt) |
Bortezomib Impurity 56
VS CAT No | : VV-B004093 |
CAS No | : 4664-57-7 |
Mol.F. | : C11H16O3S |
Mol.Wt. | : 228.3 |
Inv. Status | : In Stock |
Bortezomib Impurity 6
VS CAT No | : VV-B004011 |
CAS No | : NA |
Mol.F. | : C19H25BN4O5 |
Mol.Wt. | : 400.3 |
Inv. Status | : In Stock |
Bortezomib Impurity 7
VS CAT No | : VV-B004012 |
CAS No | : NA |
Mol.F. | : C10H16BN3O3 |
Mol.Wt. | : 237.1 |
Inv. Status | : In Stock |
Bortezomib Impurity 7
VS CAT No | : VV-B004012 |
CAS No | : NA |
Mol.F. | : C10H16BN3O3 |
Mol.Wt. | : 237.1 |
Inv. Status | : In Stock |
Bortezomib Impurity 70
VS CAT No | : VV-B004107 |
CAS No | : NA |
Mol.F. | : C19H25BN4O4 |
Mol.Wt. | : 384.2 |
Inv. Status | : In Stock |
Bortezomib Impurity 71
VS CAT No | : VV-B004108 |
CAS No | : 1579304-37-2 |
Mol.F. | : C29H39BN4O4 |
Mol.Wt. | : 518.5 |
Inv. Status | : In Stock |
Bortezomib Impurity 72
VS CAT No | : VV-B004109 |
CAS No | : NA |
Mol.F. | : C22H30N4O4 |
Mol.Wt. | : 414.5 |
Inv. Status | : In Stock |
Bortezomib Impurity 73
VS CAT No | : VV-B004110 |
CAS No | : NA |
Mol.F. | : C22H30N4O4 |
Mol.Wt. | : 414.5 |
Inv. Status | : In Stock |
Bortezomib Impurity 74
VS CAT No | : VV-B004111 |
CAS No | : NA |
Mol.F. | : C22H30N4O4 |
Mol.Wt. | : 414.5 |
Inv. Status | : In Stock |
Bortezomib Impurity 76
VS CAT No | : VV-B004123 |
CAS No | : NA |
Mol.F. | : C19H24N4O2 |
Mol.Wt. | : 340.4 |
Inv. Status | : In Stock |
Bortezomib Impurity 77
VS CAT No | : VV-B004124 |
CAS No | : NA |
Mol.F. | : C19H24N4O3 |
Mol.Wt. | : 356.4 |
Inv. Status | : In Stock |
Bortezomib Impurity 78
VS CAT No | : VV-B004125 |
CAS No | : 1135491-84-7 |
Mol.F. | : C21H44BNO2Si2 |
Mol.Wt. | : 409.6 |
Inv. Status | : In Stock |
Bortezomib Impurity 79
VS CAT No | : VV-B004127 |
CAS No | : NA |
Mol.F. | : C29H39BN4O4 |
Mol.Wt. | : 518.5 |
Inv. Status | : In Stock |
Bortezomib Impurity 8
VS CAT No | : VV-B004013 |
CAS No | : NA |
Mol.F. | : C24H27BN6O5 |
Mol.Wt. | : 490.3 |
Inv. Status | : In Stock |
Bortezomib Impurity 80
VS CAT No | : VV-B004128 |
CAS No | : 2748159-75-1 |
Mol.F. | : C14H14N4O2 |
Mol.Wt. | : 270.3 |
Inv. Status | : In Stock |
Bortezomib Impurity 81
VS CAT No | : VV-B004129 |
CAS No | : NA |
Mol.F. | : C25H36BN5O4 |
Mol.Wt. | : 481.4 |
Inv. Status | : In Stock |
Bortezomib Impurity 9
VS CAT No | : VV-B004014 |
CAS No | : 1194235-41-0 |
Mol.F. | : C28H34BN5O5 |
Mol.Wt. | : 531.4 |
Inv. Status | : In Stock |
Bortezomib Impurity A
VS CAT No | : VV-B004044 |
CAS No | : 289472-80-6 |
Mol.F. | : C14H14N4O2 |
Mol.Wt. | : 270.3 |
Inv. Status | : In Stock |
Bortezomib Impurity B
VS CAT No | : VV-B004018 |
CAS No | : NA |
Mol.F. | : C28H37BN4O5 |
Mol.Wt. | : 520.4 |
Inv. Status | : In Stock |
Bortezomib Impurity C (Mixture of Isomers)
VS CAT No | : VV-B004045 |
CAS No | : NA |
Mol.F. | : C19H25BN4O4 |
Mol.Wt. | : 384.3 |
Inv. Status | : In Stock |
Bortezomib Impurity F
VS CAT No | : VV-B004046 |
CAS No | : 73058-37-4 |
Mol.F. | : C15H15N3O3 |
Mol.Wt. | : 285.3 |
Inv. Status | : In Stock |
Bortezomib Impurity G
VS CAT No | : VV-B004047 |
CAS No | : 289472-81-7 |
Mol.F. | : C19H24N4O3 |
Mol.Wt. | : 356.4 |
Inv. Status | : In Stock |
Bortezomib Impurity H
VS CAT No | : VV-B004048 |
CAS No | : 1446194-56-4 |
Mol.F. | : C19H24N4O2 |
Mol.Wt. | : 340.4 |
Inv. Status | : In Stock |
Bortezomib Impurity M
VS CAT No | : VV-B004049 |
CAS No | : NA |
Mol.F. | : C19H24N4O4 |
Mol.Wt. | : 372.4 |
Inv. Status | : In Stock |
Bortezomib Impurity N
VS CAT No | : VV-B004050 |
CAS No | : NA |
Mol.F. | : C19H24N4O4 |
Mol.Wt. | : 372.4 |
Inv. Status | : In Stock |
Bortezomib Intermediate(R,S)
VS CAT No | : VV-B004051 |
CAS No | : 2363753-37-9 |
Mol.F. | : C14H25BO2 |
Mol.Wt. | : 236.2 |
Inv. Status | : In Stock |
Bortezomib Intermediate(S,R)
VS CAT No | : VV-B004052 |
CAS No | : 84110-34-9 |
Mol.F. | : C14H25BO2 |
Mol.Wt. | : 236.2 |
Inv. Status | : In Stock |
Bortezomib Isoamyl Impurity
VS CAT No | : VV-B004057 |
CAS No | : 1375004-39-9 |
Mol.F. | : C29H39BN4O4 |
Mol.Wt. | : 518.5 |
Inv. Status | : In Stock |
Bortezomib R and S Hydroperoxide
VS CAT No | : VV-B004079 |
CAS No | : NA |
Mol.F. | : 2(C19H24N4O4) |
Mol.Wt. | : 2(372.4) |
Inv. Status | : In Stock |
Bortezomib R-Hydroperoxide
VS CAT No | : VV-B004054 |
CAS No | : 886979-78-8 |
Mol.F. | : C19H24N4O4 |
Mol.Wt. | : 372.4 |
Inv. Status | : In Stock |
Bortezomib Related Compaund K
VS CAT No | : VV-B004069 |
CAS No | : NA |
Mol.F. | : C38H47N8O6 |
Mol.Wt. | : 711.8 |
Inv. Status | : In Stock |
Bortezomib Related Compound E
VS CAT No | : VV-B004063 |
CAS No | : NA |
Mol.F. | : C15H14N4O3 |
Mol.Wt. | : 298.3 |
Inv. Status | : In Stock |
Bortezomib Related Compound P
VS CAT No | : VV-B004074 |
CAS No | : NA |
Mol.F. | : C28H34BN5O5 |
Mol.Wt. | : 531.4 |
Inv. Status | : In Stock |
Bortezomib Related Impurity E
VS CAT No | : VV-B004042 |
CAS No | : NA |
Mol.F. | : C20H26N4O3 |
Mol.Wt. | : 370.5 |
Inv. Status | : In Stock |
Bortezomib Related Impurity F
VS CAT No | : VV-B004043 |
CAS No | : NA |
Mol.F. | : C20H26N4O3 |
Mol.Wt. | : 370.5 |
Inv. Status | : In Stock |
Bortezomib S-Hydroperoxide
VS CAT No | : VV-B004055 |
CAS No | : 886979-81-3 |
Mol.F. | : C19H24N4O4 |
Mol.Wt. | : 372.4 |
Inv. Status | : In Stock |
Bortezomib Stereo Isomers Mixture
VS CAT No | : VV-B004094 |
CAS No | : NA |
Mol.F. | : C19H25BN4O4 |
Mol.Wt. | : 384.2 |
Inv. Status | : In Stock |
Bortezomib Trimer
VS CAT No | : VV-B004015 |
CAS No | : 390800-88-1 |
Mol.F. | : C57H69B3N12O9 |
Mol.Wt. | : 1098.7 |
Inv. Status | : In Stock |
Desisobutyl-n-butyl Bortezomib
VS CAT No | : VV-B004122 |
CAS No | : 1104011-35-9 |
Mol.F. | : C19H25BN4O4 |
Mol.Wt. | : 384.2 |
Inv. Status | : In Stock |
N-(2-pyraziny| carbony|)-D-Phenylalanine
VS CAT No | : VV-B004053 |
CAS No | : 1608986-16-8 |
Mol.F. | : C14H13N3O3 |
Mol.Wt. | : 271.3 |
Inv. Status | : In Stock |
Phenylalanine Dimer Impurity
VS CAT No | : VV-B004081 |
CAS No | : NA |
Mol.F. | : C22H20N4O4 |
Mol.Wt. | : 404.4 |
Inv. Status | : In Stock |
Stable Isotopes And Metabolites
Bortezomib d5
VS CAT No | : VV-B004D01 |
CAS No | : 1133706-15-6 |
Mol.F. | : C19H20D5BN4O4 |
Mol.Wt. | : 389.3 |
Inv. Status | : In Stock |